<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.0//EN" "http://www.w3.org/TR/2001/REC-SVG-20010904/DTD/svg10.dtd">
<svg width="2400" height="2400" xmlns="http://www.w3.org/2000/svg" style="background-color:black">
<defs>
	<style type="text/css"><![CDATA[
	.sb {
	stroke-width:0.8;
	stroke-opacity:50%;
	}
	.cv {
	stroke: none;
	fill-opacity:0.15;
	}
	a:link, a:visited {
	cursor: pointer;
	}
	a:hover, a:active {
	outline: dotted 2px yellow;
	}
	g:hover, g:active {
	outline: dotted 2px yellow;
	}
	]]></style>
</defs>
<circle cx="1200" cy="1200" r="1045" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="1041" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="1040" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="1002" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="1001" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="990" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="986" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="975" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="974" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="969" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="968" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="948" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="946" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="939" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="939" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="913" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="913" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="795" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="795" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="140" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<a href="https://bcgsc.github.io/SARS2_2021">
<title>main menu</title>
<text font-size="4.0em" x="50" y="60" fill="white">SARS-CoV-2 variants 2021 timemap</text>
</a>
<text font-size="2.8em" x="50" y="105" fill="white">Genbank MN908947 vs 62,333 GISAID genomes</text>
<line x1="1200" y1="82.9384615384615" x2="1200" y2="132.938461538462" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1176" y="72.9384615384615" fill="white">Winter</text>
<line x1="2267" y1="1200" x2="2317" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="2267" y="1245" fill="white">Spring</text>
<line x1="1200" y1="2267" x2="1200" y2="2317" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1045" y="2352" fill="white">Summer</text>
<line x1="133" y1="1200" x2="73" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="59" y="1185" fill="white">Fall</text>
<g>
	<title>orf1ab gene (266-21555)</title>
	<line x1="1208" y1="1060" x2="1208" y2="405" style="stroke:grey;stroke-width:8" />
</g>
<g>
	<title>S gene (21563-25384)</title>
	<line x1="1208" y1="405" x2="1208" y2="287" style="stroke:gainsboro;stroke-width:8" />
</g>
<g>
	<title>ORF3a gene (25393-26220)</title>
	<line x1="1208" y1="287" x2="1208" y2="261" style="stroke:grey;stroke-width:8" />
</g>
<g>
	<title>E gene (26245-26472)</title>
	<line x1="1208" y1="261" x2="1208" y2="254" style="stroke:gainsboro;stroke-width:8" />
</g>
<g>
	<title>M gene (26523-27191)</title>
	<line x1="1208" y1="252" x2="1208" y2="232" style="stroke:grey;stroke-width:8" />
</g>
<g>
	<title>ORF6 gene (27202-27387)</title>
	<line x1="1208" y1="231" x2="1208" y2="226" style="stroke:gainsboro;stroke-width:8" />
</g>
<g>
	<title>ORF7a gene (27394-27759)</title>
	<line x1="1208" y1="225" x2="1208" y2="214" style="stroke:grey;stroke-width:8" />
</g>
<g>
	<title>ORF8 gene (27894-28259)</title>
	<line x1="1208" y1="210" x2="1208" y2="199" style="stroke:gainsboro;stroke-width:8" />
</g>
<g>
	<title>N gene (28274-29533)</title>
	<line x1="1208" y1="198" x2="1208" y2="160" style="stroke:grey;stroke-width:8" />
</g>
<g>
	<title>ORF10 gene (29558-29674)</title>
	<line x1="1208" y1="159" x2="1208" y2="155" style="stroke:gainsboro;stroke-width:8" />
</g>
<line x1="1200" y1="147.938461538462" x2="1200" y2="1068" style="stroke:white;stroke-width:3" />
<line x1="1204" y1="147.938461538462" x2="1210" y2="147.938461538462" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="147.938461538462" x2="1215" y2="122.938461538462" style="stroke:white;stroke-width:2" />
<line x1="1204" y1="1068" x2="1210" y2="1068" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="1068" x2="1215" y2="1093" style="stroke:white;stroke-width:2" />
<text font-size="2.0em" x="1215" y="122.938461538462" fill="white">29.9 kb</text>
<text font-size="2.0em" x="1215" y="1113" fill="white">1</text>
<text font-size="2.5em" x="75" y="175" fill="white">Continents</text>
<circle cx="60" cy="205" r="8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="215" fill="white">Europe</text>
<circle cx="60" cy="235" r="8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="245" fill="white">North America</text>
<circle cx="60" cy="265" r="8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="275" fill="white">Asia</text>
<circle cx="60" cy="295" r="8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="305" fill="white">Africa</text>
<circle cx="60" cy="325" r="8" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="335" fill="white">Oceania</text>
<circle cx="60" cy="355" r="8" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="365" fill="white">South America</text>
<circle cx="60" cy="410" r="1.90848501887865" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="101" cy="410" r="4.1655707406329" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="142" cy="410" r="8.01728549513057" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="183" cy="410" r="12.0017363099173" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<text font-size="2.0em" x="50" y="455" fill="white">2      10        100        1k</text>
<text font-size="2.0em" x="50" y="485" fill="white">genome samples</text>
<g>
	<title>2021-01-01 Europe=307</title>
	<line x1="1200.2" y1="1190.0" x2="1200.5" y2="1170.1" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-01 North America=165</title>
	<line x1="1200.5" y1="1170.1" x2="1200.8" y2="1152.3" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-01 Asia=12</title>
	<line x1="1200.8" y1="1152.3" x2="1201.0" y2="1143.4" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-01 Africa=9</title>
	<line x1="1201.0" y1="1143.4" x2="1201.1" y2="1135.4" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-01 Oceania=14</title>
	<line x1="1201.1" y1="1135.4" x2="1201.3" y2="1126.0" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-01  ATTA21993A  Europe=102 [33.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1214" cy="391" r="8" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-01  ATTA22190A  Europe=2 [0.7%]  surface glycoprotein, I210N</title>
	<circle cx="1214" cy="385" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-02 Europe=617</title>
	<line x1="1200.3" y1="1190.0" x2="1201.1" y2="1167.7" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-02 North America=385</title>
	<line x1="1201.1" y1="1167.7" x2="1201.8" y2="1147.0" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-02 Asia=12</title>
	<line x1="1201.8" y1="1147.0" x2="1202.1" y2="1138.1" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-02 Africa=20</title>
	<line x1="1202.1" y1="1138.1" x2="1202.5" y2="1127.5" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-02 Oceania=7</title>
	<line x1="1202.5" y1="1127.5" x2="1202.7" y2="1120.3" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-02 South America=6</title>
	<line x1="1202.7" y1="1120.3" x2="1203.0" y2="1113.6" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-02  ATTA21993A  Europe=231 [37.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1228" cy="391" r="9" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-02  ATTA21993A  Europe=231 [37.4%] Asia=4 [33.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1228" cy="391" r="3" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-02  ATTA21993A  North America=3 [0.8%]  surface glycoprotein, Y145H</title>
	<circle cx="1228" cy="391" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-02  T24910TCACA  Europe=3 [0.5%]  surface glycoprotein, T1117H</title>
	<circle cx="1231" cy="302" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-02  AGACA24913A  Europe=3 [0.5%]  surface glycoprotein, D1118T</title>
	<circle cx="1231" cy="302" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-02  TGTTA26157T  North America=2 [0.5%]  ORF3a protein, V256I</title>
	<circle cx="1232" cy="263" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-02  CA28253C  Europe=2 [0.3%]  ORF8 protein, I121S</title>
	<circle cx="1234" cy="199" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-03 Europe=703</title>
	<line x1="1200.5" y1="1190.0" x2="1201.7" y2="1167.3" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-03 North America=346</title>
	<line x1="1201.7" y1="1167.3" x2="1202.7" y2="1147.0" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-03 Asia=24</title>
	<line x1="1202.7" y1="1147.0" x2="1203.3" y2="1135.8" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-03 Africa=47</title>
	<line x1="1203.3" y1="1135.8" x2="1204.0" y2="1122.4" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-03 Oceania=5</title>
	<line x1="1204.0" y1="1122.4" x2="1204.3" y2="1116.2" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-03  ATTA21993A  Europe=240 [34.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1242" cy="392" r="10" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-03  ATTA21993A  North America=9 [2.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1242" cy="392" r="4" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-03  ATTA21993A  North America=9 [2.6%] Asia=5 [20.8%]  surface glycoprotein, Y145H</title>
	<circle cx="1242" cy="392" r="3" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-03  TGTT26157T  Europe=3 [0.4%]  ORF3a protein, V256N</title>
	<circle cx="1248" cy="264" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-04 Europe=3491</title>
	<line x1="1200.7" y1="1190.0" x2="1202.6" y2="1161.7" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-04 North America=923</title>
	<line x1="1202.6" y1="1161.7" x2="1204.3" y2="1138.1" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-04 Asia=55</title>
	<line x1="1204.3" y1="1138.1" x2="1205.2" y2="1124.1" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-04 Africa=26</title>
	<line x1="1205.2" y1="1124.1" x2="1206.0" y2="1112.7" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-04 Oceania=5</title>
	<line x1="1206.0" y1="1112.7" x2="1206.5" y2="1106.5" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-04 South America=9</title>
	<line x1="1206.5" y1="1106.5" x2="1207.0" y2="1098.5" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-04  TATG517T  Europe=4 [0.1%]  orf1ab polyprotein, M85V</title>
	<circle cx="1210" cy="1052" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-04  AGTT6512A  North America=3 [0.3%]  orf1ab polyprotein, S2083I</title>
	<circle cx="1223" cy="868" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-04  TT11083T  Europe=42 [1.2%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1233" cy="728" r="7" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-04  TT21576T  Europe=8 [0.2%]  surface glycoprotein, V6F</title>
	<circle cx="1255" cy="406" r="4" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-04  ATTA21993A  Europe=390 [11.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1256" cy="393" r="10" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-04  ATTA21993A  Europe=390 [11.2%] Asia=13 [23.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1256" cy="393" r="5" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-04  ATTA21993A  North America=6 [0.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1256" cy="393" r="3" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-04  ATTA22190A  Europe=11 [0.3%]  surface glycoprotein, I210N</title>
	<circle cx="1256" cy="387" r="4" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-04  T24910TCACA  Europe=2 [0.1%]  surface glycoprotein, T1117H</title>
	<circle cx="1262" cy="303" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-04  AGACA24913A  Europe=2 [0.1%]  surface glycoprotein, D1118T</title>
	<circle cx="1262" cy="303" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-04  TGTT26157T  North America=2 [0.2%]  ORF3a protein, V256N</title>
	<circle cx="1265" cy="265" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-04  GTTA26158G  Europe=2 [0.1%]  ORF3a protein, V256D</title>
	<circle cx="1265" cy="265" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-04  TT26306T  Europe=5 [0.1%]  envelope protein, A22L</title>
	<circle cx="1265" cy="261" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-04  TGT27462T  Europe=4 [0.1%]  ORF7a protein, V24*</title>
	<circle cx="1267" cy="225" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-04  CA28253C  North America=6 [0.7%]  ORF8 protein, I121S</title>
	<circle cx="1269" cy="201" r="3" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-04  CA28253C  North America=6 [0.7%] Europe=4 [0.1%]  ORF8 protein, I121S</title>
	<circle cx="1269" cy="201" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-04  CA28253C  North America=6 [0.7%] Europe=4 [0.1%] Asia=2 [3.6%]  ORF8 protein, I121S</title>
	<circle cx="1269" cy="201" r="2" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-04  AGAA28898A  Europe=4 [0.1%]  nucleocapsid phosphoprotein, R209M</title>
	<circle cx="1270" cy="181" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-04  TT29589T  Europe=49 [1.4%]  ORF10 protein, F11L</title>
	<circle cx="1272" cy="160" r="7" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-05 Europe=875</title>
	<line x1="1200.9" y1="1190.0" x2="1202.9" y2="1166.6" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-05 North America=774</title>
	<line x1="1202.9" y1="1166.6" x2="1204.9" y2="1143.6" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-05 Asia=77</title>
	<line x1="1204.9" y1="1143.6" x2="1206.2" y2="1128.5" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-05 Africa=24</title>
	<line x1="1206.2" y1="1128.5" x2="1207.1" y2="1117.3" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-05 South America=7</title>
	<line x1="1207.1" y1="1117.3" x2="1207.8" y2="1110.1" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-05  ATTA21993A  Europe=368 [42.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1270" cy="394" r="10" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-05  ATTA21993A  Europe=368 [42.1%] Asia=51 [66.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1270" cy="394" r="7" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-05  ATTA21993A  North America=12 [1.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1270" cy="394" r="4" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-05  T25704TCCC  North America=2 [0.3%]  ORF3a protein, F105P</title>
	<circle cx="1279" cy="280" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-05  TGAT27757T  Europe=2 [0.2%]  ORF7a protein, *122L</title>
	<circle cx="1285" cy="217" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-05  CA28253C  North America=3 [0.4%]  ORF8 protein, I121S</title>
	<circle cx="1286" cy="202" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-06 Europe=605</title>
	<line x1="1201.0" y1="1190.1" x2="1203.3" y2="1167.9" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-06 North America=674</title>
	<line x1="1203.3" y1="1167.9" x2="1205.7" y2="1145.4" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-06 Asia=21</title>
	<line x1="1205.7" y1="1145.4" x2="1206.8" y2="1134.7" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-06 Africa=10</title>
	<line x1="1206.8" y1="1134.7" x2="1207.6" y2="1126.4" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-06 Oceania=10</title>
	<line x1="1207.6" y1="1126.4" x2="1208.5" y2="1118.1" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-06 South America=6</title>
	<line x1="1208.5" y1="1118.1" x2="1209.2" y2="1111.4" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-06  ATTA21993A  Europe=229 [37.9%]  surface glycoprotein, Y145H</title>
	<circle cx="1283" cy="395" r="9" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-06  ATTA21993A  North America=13 [1.9%]  surface glycoprotein, Y145H</title>
	<circle cx="1283" cy="395" r="5" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-06  ATTA21993A  North America=13 [1.9%] Asia=11 [52.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1283" cy="395" r="4" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-06  T24910TCACA  Europe=3 [0.5%]  surface glycoprotein, T1117H</title>
	<circle cx="1293" cy="306" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-06  AGACA24913A  Europe=3 [0.5%]  surface glycoprotein, D1118T</title>
	<circle cx="1293" cy="306" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-06  G25767GAAT  North America=2 [0.3%]  ORF3a protein, R126N</title>
	<circle cx="1295" cy="280" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-06  CA28253C  North America=9 [1.3%]  ORF8 protein, I121S</title>
	<circle cx="1303" cy="204" r="4" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-06  CA28253C  North America=9 [1.3%] Europe=2 [0.3%]  ORF8 protein, I121S</title>
	<circle cx="1303" cy="204" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-07 Europe=978</title>
	<line x1="1201.2" y1="1190.1" x2="1204.1" y2="1166.3" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-07 North America=546</title>
	<line x1="1204.1" y1="1166.3" x2="1206.7" y2="1144.6" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-07 Asia=10</title>
	<line x1="1206.7" y1="1144.6" x2="1207.7" y2="1136.3" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-07 Africa=17</title>
	<line x1="1207.7" y1="1136.3" x2="1208.9" y2="1126.3" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-07 South America=7</title>
	<line x1="1208.9" y1="1126.3" x2="1209.8" y2="1119.2" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-07  AGTT6512A  Europe=4 [0.4%]  orf1ab polyprotein, S2083I</title>
	<circle cx="1240" cy="870" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-07  ATTA21993A  Europe=573 [58.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1297" cy="397" r="11" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-07  ATTA21993A  North America=13 [2.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1297" cy="397" r="5" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-07  ATTA21993A  North America=13 [2.4%] Africa=5 [29.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1297" cy="397" r="3" style="fill:orange;" class="cv" />
</g>
<g>
	<title>2021-01-07  ATTA21993A  North America=13 [2.4%] Africa=5 [29.4%] Asia=3 [30.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1297" cy="397" r="2" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-07  ATTA21993A  North America=13 [2.4%] Africa=5 [29.4%] Asia=3 [30.0%] South America=2 [28.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1297" cy="397" r="2" style="fill:lime;" class="cv" />
</g>
<g>
	<title>2021-01-07  GTTA26158G  Europe=2 [0.2%]  ORF3a protein, V256D</title>
	<circle cx="1313" cy="270" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-07  CA28253C  North America=4 [0.7%]  ORF8 protein, I121S</title>
	<circle cx="1320" cy="206" r="3" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-07  CA28253C  North America=4 [0.7%] Asia=2 [20.0%]  ORF8 protein, I121S</title>
	<circle cx="1320" cy="206" r="2" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-07  G29601GTA  Europe=4 [0.4%]  ORF10 protein, L16I</title>
	<circle cx="1325" cy="164" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-08 Europe=881</title>
	<line x1="1201.4" y1="1190.1" x2="1204.6" y2="1166.8" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-08 North America=658</title>
	<line x1="1204.6" y1="1166.8" x2="1207.7" y2="1144.4" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-08 Asia=12</title>
	<line x1="1207.7" y1="1144.4" x2="1208.9" y2="1135.6" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-08 Africa=5</title>
	<line x1="1208.9" y1="1135.6" x2="1209.8" y2="1129.4" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-08 Oceania=8</title>
	<line x1="1209.8" y1="1129.4" x2="1210.8" y2="1121.9" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-08 South America=7</title>
	<line x1="1210.8" y1="1121.9" x2="1211.8" y2="1114.7" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-08  ATAA3951A  North America=2 [0.3%]  orf1ab polyprotein, D1229E</title>
	<circle cx="1235" cy="949" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-08  ATTA21993A  Europe=468 [53.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1311" cy="399" r="11" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-08  ATTA21993A  North America=4 [0.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1311" cy="399" r="3" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-08  ATTA21993A  North America=4 [0.6%] Oceania=3 [37.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1311" cy="399" r="2" style="fill:yellow;" class="cv" />
</g>
<g>
	<title>2021-01-08  ATTA22190A  Europe=2 [0.2%]  surface glycoprotein, I210N</title>
	<circle cx="1312" cy="393" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-08  G25767GAAT  North America=2 [0.3%]  ORF3a protein, R126N</title>
	<circle cx="1327" cy="284" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-08  CA28253C  North America=3 [0.5%]  ORF8 protein, I121S</title>
	<circle cx="1337" cy="208" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-09 Europe=1002</title>
	<line x1="1201.5" y1="1190.1" x2="1205.3" y2="1166.4" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-09 North America=453</title>
	<line x1="1205.3" y1="1166.4" x2="1208.5" y2="1145.4" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-09 Asia=7</title>
	<line x1="1208.5" y1="1145.4" x2="1209.6" y2="1138.3" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-09 Africa=45</title>
	<line x1="1209.6" y1="1138.3" x2="1211.7" y2="1125.1" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-09 Oceania=5</title>
	<line x1="1211.7" y1="1125.1" x2="1212.7" y2="1119.0" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-09  ATTA21993A  Europe=598 [59.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1325" cy="401" r="11" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-09  ATTA21993A  North America=6 [1.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1325" cy="401" r="3" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-09  ATTA21993A  North America=6 [1.3%] Africa=3 [6.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1325" cy="401" r="2" style="fill:orange;" class="cv" />
</g>
<g>
	<title>2021-01-09  TCTA23480T  North America=2 [0.4%]  surface glycoprotein, S640Y</title>
	<circle cx="1332" cy="356" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-09  T24910TCACA  Europe=2 [0.2%]  surface glycoprotein, T1117H</title>
	<circle cx="1339" cy="312" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-09  AGACA24913A  Europe=2 [0.2%]  surface glycoprotein, D1118T</title>
	<circle cx="1339" cy="312" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-10 Europe=981</title>
	<line x1="1201.7" y1="1190.1" x2="1205.8" y2="1166.6" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-10 North America=274</title>
	<line x1="1205.8" y1="1166.6" x2="1209.2" y2="1147.3" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-10 Asia=4</title>
	<line x1="1209.2" y1="1147.3" x2="1210.1" y2="1141.8" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-10 Africa=5</title>
	<line x1="1210.1" y1="1141.8" x2="1211.2" y2="1135.7" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-10 Oceania=6</title>
	<line x1="1211.2" y1="1135.7" x2="1212.3" y2="1129.0" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-10 South America=4</title>
	<line x1="1212.3" y1="1129.0" x2="1213.3" y2="1123.5" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-10  ATTA21993A  Europe=630 [64.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1339" cy="403" r="11" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-10  ATTA21993A  North America=7 [2.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1339" cy="403" r="4" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-11 Europe=4402</title>
	<line x1="1201.9" y1="1190.2" x2="1207.4" y2="1161.5" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-11 North America=618</title>
	<line x1="1207.4" y1="1161.5" x2="1211.6" y2="1139.6" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-11 Asia=100</title>
	<line x1="1211.6" y1="1139.6" x2="1214.6" y2="1123.9" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-11 Africa=46</title>
	<line x1="1214.6" y1="1123.9" x2="1217.1" y2="1110.7" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-11 Oceania=2</title>
	<line x1="1217.1" y1="1110.7" x2="1217.8" y2="1107.0" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-11 South America=2</title>
	<line x1="1217.8" y1="1107.0" x2="1218.5" y2="1103.2" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-11  TTAT516T  Europe=6 [0.1%]  orf1ab polyprotein, M85V</title>
	<circle cx="1228" cy="1054" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-11  TATG517T  Europe=3 [0.1%]  orf1ab polyprotein, M85V</title>
	<circle cx="1228" cy="1054" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-11  AATA6509A  Europe=4 [0.1%]  orf1ab polyprotein, N2082S</title>
	<circle cx="1263" cy="873" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-11  TT11083T  Europe=30 [0.7%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1289" cy="735" r="6" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-11  TT21576T  Europe=4 [0.1%]  surface glycoprotein, V6F</title>
	<circle cx="1350" cy="418" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-11  ATTA21993A  Europe=1465 [33.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1352" cy="405" r="13" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-11  ATTA21993A  North America=25 [4.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1352" cy="405" r="6" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-11  ATTA21993A  North America=25 [4.0%] Asia=24 [24.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1352" cy="405" r="6" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-11  ATTA21993A  North America=25 [4.0%] Asia=24 [24.0%] Africa=21 [45.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1352" cy="405" r="5" style="fill:orange;" class="cv" />
</g>
<g>
	<title>2021-01-11  ATTA22190A  Europe=13 [0.3%]  surface glycoprotein, I210N</title>
	<circle cx="1353" cy="400" r="5" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-11  GTTA26158G  Europe=2 [0.0%]  ORF3a protein, V256D</title>
	<circle cx="1376" cy="280" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-11  TT26306T  Europe=10 [0.2%]  envelope protein, A22L</title>
	<circle cx="1377" cy="275" r="4" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-11  TAT28031T  North America=2 [0.3%]  ORF8 protein, I47*</title>
	<circle cx="1387" cy="223" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-11  AGAA28898A  Europe=3 [0.1%]  nucleocapsid phosphoprotein, R209M</title>
	<circle cx="1392" cy="197" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-11  TT29589T  Europe=20 [0.5%]  ORF10 protein, F11L</title>
	<circle cx="1396" cy="176" r="5" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-12 Europe=2225</title>
	<line x1="1202.1" y1="1190.2" x2="1207.5" y2="1164.0" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-12 North America=521</title>
	<line x1="1207.5" y1="1164.0" x2="1212.0" y2="1142.7" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-12 Asia=60</title>
	<line x1="1212.0" y1="1142.7" x2="1214.9" y2="1128.7" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-12 Africa=16</title>
	<line x1="1214.9" y1="1128.7" x2="1217.0" y2="1119.1" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-12 Oceania=2</title>
	<line x1="1217.0" y1="1119.1" x2="1217.7" y2="1115.4" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-12 South America=4</title>
	<line x1="1217.7" y1="1115.4" x2="1218.9" y2="1109.9" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-12  ATTA9859A  North America=2 [0.4%]  orf1ab polyprotein, L3199P</title>
	<circle cx="1289" cy="774" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-12  ATTA21993A  Europe=1398 [62.8%]  surface glycoprotein, Y145H</title>
	<circle cx="1366" cy="408" r="13" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-12  ATTA21993A  North America=21 [4.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1366" cy="408" r="5" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-12  ATTA21993A  North America=21 [4.0%] Asia=19 [31.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1366" cy="408" r="5" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-12  ATTA21993A  Africa=2 [12.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1366" cy="408" r="2" style="fill:orange;" class="cv" />
</g>
<g>
	<title>2021-01-12  GTTA26158G  Europe=2 [0.1%]  ORF3a protein, V256D</title>
	<circle cx="1392" cy="283" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-12  AATT27578A  Europe=19 [0.9%]  ORF7a protein, Q62H</title>
	<circle cx="1401" cy="240" r="5" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-13 Europe=1519</title>
	<line x1="1202.2" y1="1190.2" x2="1207.9" y2="1165.4" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-13 North America=429</title>
	<line x1="1207.9" y1="1165.4" x2="1212.5" y2="1144.9" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-13 Asia=36</title>
	<line x1="1212.5" y1="1144.9" x2="1215.3" y2="1132.7" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-13 Africa=11</title>
	<line x1="1215.3" y1="1132.7" x2="1217.2" y2="1124.2" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-13 Oceania=4</title>
	<line x1="1217.2" y1="1124.2" x2="1218.5" y2="1118.8" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-13 South America=7</title>
	<line x1="1218.5" y1="1118.8" x2="1220.1" y2="1111.7" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-13  ATTA21993A  Europe=862 [56.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1380" cy="411" r="12" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-13  ATTA21993A  North America=18 [4.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1380" cy="411" r="5" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-13  ATTA21993A  North America=18 [4.2%] Asia=9 [25.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1380" cy="411" r="4" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-13  ATTA21993A  Africa=2 [18.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1380" cy="411" r="2" style="fill:orange;" class="cv" />
</g>
<g>
	<title>2021-01-13  T24910TCACA  Europe=3 [0.2%]  surface glycoprotein, T1117H</title>
	<circle cx="1399" cy="324" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-13  AGACA24913A  Europe=3 [0.2%]  surface glycoprotein, D1118T</title>
	<circle cx="1399" cy="324" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-13  GTTA26158G  Europe=2 [0.1%]  ORF3a protein, V256D</title>
	<circle cx="1408" cy="286" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-14 Europe=1805</title>
	<line x1="1202.4" y1="1190.3" x2="1208.6" y2="1165.0" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-14 North America=488</title>
	<line x1="1208.6" y1="1165.0" x2="1213.7" y2="1144.1" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-14 Asia=40</title>
	<line x1="1213.7" y1="1144.1" x2="1216.8" y2="1131.6" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-14 Africa=16</title>
	<line x1="1216.8" y1="1131.6" x2="1219.2" y2="1122.0" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-14 Oceania=5</title>
	<line x1="1219.2" y1="1122.0" x2="1220.7" y2="1116.0" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-14 South America=4</title>
	<line x1="1220.7" y1="1116.0" x2="1222.0" y2="1110.5" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-14  ATAA3951A  North America=2 [0.4%]  orf1ab polyprotein, D1229E</title>
	<circle cx="1261" cy="953" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-14  AGTT6512A  Europe=3 [0.2%]  orf1ab polyprotein, S2083I</title>
	<circle cx="1279" cy="877" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-14  ATTA9859A  North America=2 [0.4%]  orf1ab polyprotein, L3199P</title>
	<circle cx="1304" cy="777" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-14  ATTA21993A  Europe=1204 [66.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1393" cy="414" r="12" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-14  ATTA21993A  North America=34 [7.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1393" cy="414" r="6" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-14  ATTA21993A  North America=34 [7.0%] Asia=24 [60.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1393" cy="414" r="6" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-14  ATTA21993A  Oceania=2 [40.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1393" cy="414" r="2" style="fill:yellow;" class="cv" />
</g>
<g>
	<title>2021-01-14  ATTA22190A  Europe=2 [0.1%]  surface glycoprotein, I210N</title>
	<circle cx="1395" cy="409" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-15 Europe=1812</title>
	<line x1="1202.6" y1="1190.3" x2="1209.2" y2="1165.1" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-15 North America=483</title>
	<line x1="1209.2" y1="1165.1" x2="1214.7" y2="1144.4" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-15 Asia=13</title>
	<line x1="1214.7" y1="1144.4" x2="1217.0" y2="1135.5" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-15 Africa=37</title>
	<line x1="1217.0" y1="1135.5" x2="1220.3" y2="1123.3" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-15 Oceania=10</title>
	<line x1="1220.3" y1="1123.3" x2="1222.4" y2="1115.2" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-15 South America=21</title>
	<line x1="1222.4" y1="1115.2" x2="1225.1" y2="1104.8" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-15  G18634GT  North America=2 [0.4%]  orf1ab polyprotein, K6125E</title>
	<circle cx="1380" cy="518" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-15  ATTA21993A  Europe=1227 [67.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1407" cy="418" r="12" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-15  ATTA21993A  North America=11 [2.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1407" cy="418" r="4" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-15  ATTA21993A  North America=11 [2.3%] Oceania=3 [30.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1407" cy="418" r="2" style="fill:yellow;" class="cv" />
</g>
<g>
	<title>2021-01-15  ATTA21993A  Asia=3 [23.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1407" cy="418" r="2" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-16 Europe=1092</title>
	<line x1="1202.7" y1="1190.4" x2="1209.3" y2="1167.0" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-16 North America=289</title>
	<line x1="1209.3" y1="1167.0" x2="1214.7" y2="1148.0" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-16 Asia=6</title>
	<line x1="1214.7" y1="1148.0" x2="1216.5" y2="1141.5" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-16 Africa=9</title>
	<line x1="1216.5" y1="1141.5" x2="1218.7" y2="1133.8" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-16 Oceania=5</title>
	<line x1="1218.7" y1="1133.8" x2="1220.4" y2="1127.8" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-16  ATTA21993A  Europe=767 [70.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1420" cy="422" r="12" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-16  ATTA21993A  North America=33 [11.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1420" cy="422" r="6" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-16  ATTA21993A  North America=33 [11.4%] Oceania=4 [80.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1420" cy="422" r="3" style="fill:yellow;" class="cv" />
</g>
<g>
	<title>2021-01-16  ATTA21993A  Asia=2 [33.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1420" cy="422" r="2" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-17 Europe=1340</title>
	<line x1="1202.9" y1="1190.4" x2="1210.1" y2="1166.5" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-17 North America=190</title>
	<line x1="1210.1" y1="1166.5" x2="1215.4" y2="1149.0" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-17 Asia=10</title>
	<line x1="1215.4" y1="1149.0" x2="1217.8" y2="1141.0" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-17 Oceania=4</title>
	<line x1="1217.8" y1="1141.0" x2="1219.4" y2="1135.7" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-17  ATTA21993A  Europe=1006 [75.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1433" cy="425" r="12" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-17  ATTA21993A  North America=17 [8.9%]  surface glycoprotein, Y145H</title>
	<circle cx="1433" cy="425" r="5" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-18 Europe=4019</title>
	<line x1="1203.0" y1="1190.5" x2="1211.8" y2="1163.0" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-18 North America=402</title>
	<line x1="1211.8" y1="1163.0" x2="1218.2" y2="1143.2" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-18 Asia=12</title>
	<line x1="1218.2" y1="1143.2" x2="1220.9" y2="1134.7" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-18 Africa=5</title>
	<line x1="1220.9" y1="1134.7" x2="1222.8" y2="1128.7" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-18 Oceania=7</title>
	<line x1="1222.8" y1="1128.7" x2="1225.0" y2="1121.9" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-18 South America=9</title>
	<line x1="1225.0" y1="1121.9" x2="1227.4" y2="1114.2" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-18  TTAT516T  Europe=2 [0.0%]  orf1ab polyprotein, M85V</title>
	<circle cx="1245" cy="1059" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-18  CG8888C  North America=4 [1.0%]  orf1ab polyprotein, R2875P</title>
	<circle cx="1324" cy="814" r="3" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-18  TT11083T  Europe=27 [0.7%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1344" cy="749" r="6" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-18  G18634GT  North America=5 [1.2%]  orf1ab polyprotein, K6125E</title>
	<circle cx="1415" cy="528" r="3" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-18  TT21576T  Europe=3 [0.1%]  surface glycoprotein, V6F</title>
	<circle cx="1443" cy="442" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-18  ATTA21993A  Europe=1470 [36.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1447" cy="430" r="13" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-18  ATTA21993A  North America=27 [6.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1447" cy="430" r="6" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-18  ATTA21993A  North America=27 [6.7%] Oceania=3 [42.9%]  surface glycoprotein, Y145H</title>
	<circle cx="1447" cy="430" r="2" style="fill:yellow;" class="cv" />
</g>
<g>
	<title>2021-01-18  ATTA21993A  Asia=2 [16.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1447" cy="430" r="2" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-18  ATTA22190A  Europe=4 [0.1%]  surface glycoprotein, I210N</title>
	<circle cx="1448" cy="424" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-18  T24910TCACA  Europe=3 [0.1%]  surface glycoprotein, T1117H</title>
	<circle cx="1474" cy="344" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-18  AGACA24913A  Europe=3 [0.1%]  surface glycoprotein, D1118T</title>
	<circle cx="1474" cy="344" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-18  TGTT26157T  Europe=2 [0.0%]  ORF3a protein, V256N</title>
	<circle cx="1486" cy="308" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-18  GTTA26158G  Europe=5 [0.1%]  ORF3a protein, V256D</title>
	<circle cx="1486" cy="307" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-18  TT26306T  Europe=5 [0.1%]  envelope protein, A22L</title>
	<circle cx="1487" cy="303" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-18  TAT28031T  North America=3 [0.7%]  ORF8 protein, I47*</title>
	<circle cx="1503" cy="253" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-18  TT29589T  Europe=13 [0.3%]  ORF10 protein, F11L</title>
	<circle cx="1518" cy="207" r="5" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-19 Europe=1496</title>
	<line x1="1203.2" y1="1190.5" x2="1211.4" y2="1166.5" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-19 North America=469</title>
	<line x1="1211.4" y1="1166.5" x2="1218.2" y2="1146.2" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-19 Asia=48</title>
	<line x1="1218.2" y1="1146.2" x2="1222.6" y2="1133.4" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-19 Africa=2</title>
	<line x1="1222.6" y1="1133.4" x2="1223.8" y2="1129.8" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-19 Oceania=2</title>
	<line x1="1223.8" y1="1129.8" x2="1225.0" y2="1126.2" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-19 South America=25</title>
	<line x1="1225.0" y1="1126.2" x2="1228.7" y2="1115.5" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-19  CG8888C  North America=3 [0.6%]  orf1ab polyprotein, R2875P</title>
	<circle cx="1330" cy="816" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-19  G18634GT  North America=2 [0.4%]  orf1ab polyprotein, K6125E</title>
	<circle cx="1427" cy="532" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-19  ATTA21993A  Europe=1138 [76.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1460" cy="434" r="12" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-19  ATTA21993A  North America=21 [4.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1460" cy="434" r="5" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-19  ATTA21993A  North America=21 [4.5%] Asia=19 [39.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1460" cy="434" r="5" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-19  ATTA21993A  South America=3 [12.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1460" cy="434" r="2" style="fill:lime;" class="cv" />
</g>
<g>
	<title>2021-01-19  ATTA22190A  Europe=2 [0.1%]  surface glycoprotein, I210N</title>
	<circle cx="1462" cy="428" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-19  TAT28031T  North America=2 [0.4%]  ORF8 protein, I47*</title>
	<circle cx="1520" cy="258" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-19  AATT28064A  Europe=2 [0.1%]  ORF8 protein, I58E</title>
	<circle cx="1520" cy="257" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-19  CA28253C  North America=2 [0.4%]  ORF8 protein, I121S</title>
	<circle cx="1522" cy="251" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-20 Europe=1282</title>
	<line x1="1203.4" y1="1190.6" x2="1211.8" y2="1167.2" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-20 North America=298</title>
	<line x1="1211.8" y1="1167.2" x2="1218.5" y2="1148.5" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-20 Asia=15</title>
	<line x1="1218.5" y1="1148.5" x2="1221.7" y2="1139.5" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-20 Oceania=2</title>
	<line x1="1221.7" y1="1139.5" x2="1223.0" y2="1135.9" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-20 South America=12</title>
	<line x1="1223.0" y1="1135.9" x2="1226.0" y2="1127.5" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-20  CG8888C  North America=3 [1.0%]  orf1ab polyprotein, R2875P</title>
	<circle cx="1337" cy="818" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-20  G18634GT  North America=6 [2.0%]  orf1ab polyprotein, K6125E</title>
	<circle cx="1438" cy="536" r="3" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-20  ATTA21993A  Europe=847 [66.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1473" cy="439" r="12" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-20  ATTA21993A  North America=22 [7.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1473" cy="439" r="5" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-20  ATTA21993A  North America=22 [7.4%] Asia=10 [66.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1473" cy="439" r="4" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-21 Europe=1181</title>
	<line x1="1203.5" y1="1190.6" x2="1212.2" y2="1167.7" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-21 North America=202</title>
	<line x1="1212.2" y1="1167.7" x2="1218.8" y2="1150.4" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-21 Asia=72</title>
	<line x1="1218.8" y1="1150.4" x2="1224.0" y2="1136.4" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-21 Oceania=4</title>
	<line x1="1224.0" y1="1136.4" x2="1226.0" y2="1131.2" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-21 South America=5</title>
	<line x1="1226.0" y1="1131.2" x2="1228.2" y2="1125.4" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-21  CG8888C  North America=2 [1.0%]  orf1ab polyprotein, R2875P</title>
	<circle cx="1343" cy="820" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-21  G18634GT  North America=2 [1.0%]  orf1ab polyprotein, K6125E</title>
	<circle cx="1450" cy="540" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-21  ATTA21993A  Europe=848 [71.8%]  surface glycoprotein, Y145H</title>
	<circle cx="1486" cy="443" r="12" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-21  ATTA21993A  Asia=45 [62.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1486" cy="443" r="7" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-21  ATTA21993A  North America=12 [5.9%]  surface glycoprotein, Y145H</title>
	<circle cx="1486" cy="443" r="4" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-21  ATTA21993A  North America=12 [5.9%] Oceania=2 [50.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1486" cy="443" r="2" style="fill:yellow;" class="cv" />
</g>
<g>
	<title>2021-01-21  TGTT26157T  Europe=2 [0.2%]  ORF3a protein, V256N</title>
	<circle cx="1531" cy="323" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-22 Europe=1677</title>
	<line x1="1203.7" y1="1190.7" x2="1213.2" y2="1166.7" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-22 North America=163</title>
	<line x1="1213.2" y1="1166.7" x2="1219.8" y2="1150.3" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-22 Asia=29</title>
	<line x1="1219.8" y1="1150.3" x2="1224.2" y2="1139.3" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-22 Africa=2</title>
	<line x1="1224.2" y1="1139.3" x2="1225.6" y2="1135.7" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-22 Oceania=4</title>
	<line x1="1225.6" y1="1135.7" x2="1227.6" y2="1130.6" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-22 South America=12</title>
	<line x1="1227.6" y1="1130.6" x2="1230.9" y2="1122.3" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-22  TATG517T  Europe=2 [0.1%]  orf1ab polyprotein, M85V</title>
	<circle cx="1255" cy="1062" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-22  ATTA21993A  Europe=1351 [80.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1499" cy="448" r="13" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-22  ATTA21993A  Asia=20 [69.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1499" cy="448" r="5" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-22  ATTA21993A  North America=10 [6.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1499" cy="448" r="4" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-22  ATTA21993A  North America=10 [6.1%] South America=3 [25.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1499" cy="448" r="2" style="fill:lime;" class="cv" />
</g>
<g>
	<title>2021-01-22  AATT27578A  Europe=5 [0.3%]  ORF7a protein, Q62H</title>
	<circle cx="1563" cy="289" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-22  ACAA28996A  Europe=2 [0.1%]  nucleocapsid phosphoprotein, Q242G</title>
	<circle cx="1579" cy="248" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-23 Europe=1234</title>
	<line x1="1203.9" y1="1190.8" x2="1213.4" y2="1168.0" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-23 North America=114</title>
	<line x1="1213.4" y1="1168.0" x2="1219.7" y2="1152.7" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-23 Asia=9</title>
	<line x1="1219.7" y1="1152.7" x2="1222.8" y2="1145.4" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-23 Oceania=4</title>
	<line x1="1222.8" y1="1145.4" x2="1225.0" y2="1140.2" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-23  ATTA21993A  Europe=975 [79.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1512" cy="454" r="12" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-23  ATTA21993A  North America=8 [7.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1512" cy="454" r="4" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-23  ATTA21993A  North America=8 [7.0%] Oceania=4 [100.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1512" cy="454" r="3" style="fill:yellow;" class="cv" />
</g>
<g>
	<title>2021-01-23  ATTA21993A  Asia=2 [22.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1512" cy="454" r="2" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-24 Europe=890</title>
	<line x1="1204.0" y1="1190.8" x2="1213.5" y2="1169.2" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-24 North America=55</title>
	<line x1="1213.5" y1="1169.2" x2="1219.1" y2="1156.4" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-24 Asia=7</title>
	<line x1="1219.1" y1="1156.4" x2="1222.0" y2="1149.8" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-24 Oceania=3</title>
	<line x1="1222.0" y1="1149.8" x2="1223.9" y2="1145.4" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-24 South America=4</title>
	<line x1="1223.9" y1="1145.4" x2="1226.2" y2="1140.3" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-24  TTTT21981T  Europe=3 [0.3%]  surface glycoprotein, F140L</title>
	<circle cx="1525" cy="459" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-24  ATTA21993A  Europe=723 [81.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1525" cy="459" r="11" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-24  ATTA21993A  Asia=2 [28.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1525" cy="459" r="2" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-24  AATT28064A  Europe=2 [0.2%]  ORF8 protein, I58E</title>
	<circle cx="1600" cy="288" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-25 Europe=3987</title>
	<line x1="1204.2" y1="1190.9" x2="1216.2" y2="1164.7" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-25 North America=215</title>
	<line x1="1216.2" y1="1164.7" x2="1224.0" y2="1147.8" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-25 Asia=13</title>
	<line x1="1224.0" y1="1147.8" x2="1227.8" y2="1139.4" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-25 South America=9</title>
	<line x1="1227.8" y1="1139.4" x2="1231.1" y2="1132.2" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-25  TATG517T  Europe=2 [0.1%]  orf1ab polyprotein, M85V</title>
	<circle cx="1262" cy="1065" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-25  TT11083T  Europe=9 [0.2%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1397" cy="770" r="4" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-25  ATTA21993A  Europe=2173 [54.5%]  surface glycoprotein, Y145H</title>
	<circle cx="1538" cy="465" r="13" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-25  ATTA21993A  North America=13 [6.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1538" cy="465" r="5" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-25  ATTA21993A  North America=13 [6.0%] Asia=3 [23.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1538" cy="465" r="2" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-25  ATTA22190A  Europe=3 [0.1%]  surface glycoprotein, I210N</title>
	<circle cx="1540" cy="459" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-25  T24910TCACA  Europe=7 [0.2%]  surface glycoprotein, T1117H</title>
	<circle cx="1575" cy="383" r="4" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-25  AGACA24913A  Europe=7 [0.2%]  surface glycoprotein, D1118T</title>
	<circle cx="1575" cy="383" r="4" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-25  GTTA26158G  Europe=4 [0.1%]  ORF3a protein, V256D</title>
	<circle cx="1591" cy="348" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-25  TT26306T  Europe=4 [0.1%]  envelope protein, A22L</title>
	<circle cx="1593" cy="344" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-25  GTTT27204G  Europe=4 [0.1%]  ORF6 protein, F2H</title>
	<circle cx="1604" cy="319" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-25  CA28253C  North America=2 [0.9%]  ORF8 protein, I121S</title>
	<circle cx="1618" cy="290" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-25  TCTG28277T  Europe=4 [0.1%]  nucleocapsid phosphoprotein, S2Y</title>
	<circle cx="1618" cy="289" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-25  TT29589T  Europe=4 [0.1%]  ORF10 protein, F11L</title>
	<circle cx="1635" cy="252" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-26 Europe=1674</title>
	<line x1="1204.3" y1="1191.0" x2="1215.5" y2="1167.7" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-26 North America=239</title>
	<line x1="1215.5" y1="1167.7" x2="1223.7" y2="1150.6" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-26 Asia=8</title>
	<line x1="1223.7" y1="1150.6" x2="1227.0" y2="1143.7" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-26 Africa=2</title>
	<line x1="1227.0" y1="1143.7" x2="1228.7" y2="1140.2" style="stroke:orange;" class="sb" />
</g>
<g>
	<title>2021-01-26  ATTA21993A  Europe=1312 [78.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1550" cy="471" r="12" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-26  ATTA21993A  North America=12 [5.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1550" cy="471" r="4" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-26  AATT27578A  Europe=5 [0.3%]  ORF7a protein, Q62H</title>
	<circle cx="1624" cy="316" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-27 Europe=1139</title>
	<line x1="1204.5" y1="1191.1" x2="1215.4" y2="1169.2" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-27 North America=266</title>
	<line x1="1215.4" y1="1169.2" x2="1224.1" y2="1151.8" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-27 Asia=9</title>
	<line x1="1224.1" y1="1151.8" x2="1227.7" y2="1144.7" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-27  ACACCT1056A  North America=2 [0.8%]  orf1ab polyprotein, T265Q</title>
	<circle cx="1274" cy="1053" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-27  T1057TTATCT  North America=2 [0.8%]  orf1ab polyprotein, T265Y</title>
	<circle cx="1274" cy="1053" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-27  ATTA21993A  Europe=922 [80.9%]  surface glycoprotein, Y145H</title>
	<circle cx="1563" cy="477" r="12" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-27  ATTA21993A  North America=23 [8.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1563" cy="477" r="6" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-27  ATTA21993A  North America=23 [8.6%] Asia=5 [55.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1563" cy="477" r="3" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-28 Europe=1556</title>
	<line x1="1204.6" y1="1191.1" x2="1216.5" y2="1168.5" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-28 North America=197</title>
	<line x1="1216.5" y1="1168.5" x2="1225.0" y2="1152.2" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-28 Asia=7</title>
	<line x1="1225.0" y1="1152.2" x2="1228.3" y2="1145.8" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-28 Oceania=2</title>
	<line x1="1228.3" y1="1145.8" x2="1230.1" y2="1142.4" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-01-28 South America=3</title>
	<line x1="1230.1" y1="1142.4" x2="1232.3" y2="1138.2" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-01-28  G21578GTTT  Europe=2 [0.1%]  surface glycoprotein, L7F</title>
	<circle cx="1569" cy="495" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-28  ATTA21993A  Europe=1370 [88.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1575" cy="483" r="13" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-28  ATTA21993A  North America=12 [6.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1575" cy="483" r="4" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-28  ATTA21993A  North America=12 [6.1%] Asia=2 [28.6%]  surface glycoprotein, Y145H</title>
	<circle cx="1575" cy="483" r="2" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-28  AATT27578A  Europe=3 [0.2%]  ORF7a protein, Q62H</title>
	<circle cx="1655" cy="331" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-29 Europe=1727</title>
	<line x1="1204.8" y1="1191.2" x2="1217.2" y2="1168.5" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-29 North America=129</title>
	<line x1="1217.2" y1="1168.5" x2="1225.3" y2="1153.6" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-29 Asia=5</title>
	<line x1="1225.3" y1="1153.6" x2="1228.3" y2="1148.2" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-29  TATG517T  Europe=3 [0.2%]  orf1ab polyprotein, M85V</title>
	<circle cx="1271" cy="1070" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-29  ATTA21993A  Europe=1532 [88.7%]  surface glycoprotein, Y145H</title>
	<circle cx="1587" cy="490" r="13" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-29  ATTA21993A  North America=12 [9.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1587" cy="490" r="4" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-29  ATTA21993A  North America=12 [9.3%] Asia=2 [40.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1587" cy="490" r="2" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-01-29  TGTT26157T  Europe=2 [0.1%]  ORF3a protein, V256N</title>
	<circle cx="1649" cy="377" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-29  AATT27578A  Europe=2 [0.1%]  ORF7a protein, Q62H</title>
	<circle cx="1670" cy="339" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-30 Europe=1340</title>
	<line x1="1204.9" y1="1191.3" x2="1217.3" y2="1169.5" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-30 North America=41</title>
	<line x1="1217.3" y1="1169.5" x2="1223.7" y2="1158.3" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-30 Asia=7</title>
	<line x1="1223.7" y1="1158.3" x2="1227.3" y2="1152.0" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-30  ATTA21993A  Europe=1178 [87.9%]  surface glycoprotein, Y145H</title>
	<circle cx="1599" cy="497" r="12" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-30  ATTA21993A  North America=4 [9.8%]  surface glycoprotein, Y145H</title>
	<circle cx="1599" cy="497" r="3" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-01-30  TGTT26157T  Europe=2 [0.1%]  ORF3a protein, V256N</title>
	<circle cx="1663" cy="385" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-30  TGAT27757T  Europe=2 [0.1%]  ORF7a protein, *122L</title>
	<circle cx="1687" cy="342" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-30  AATT28064A  Europe=3 [0.2%]  ORF8 protein, I58E</title>
	<circle cx="1692" cy="334" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-31 Europe=452</title>
	<line x1="1205.1" y1="1191.4" x2="1215.9" y2="1173.1" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-01-31 North America=26</title>
	<line x1="1215.9" y1="1173.1" x2="1221.7" y2="1163.2" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-01-31 Asia=6</title>
	<line x1="1221.7" y1="1163.2" x2="1225.2" y2="1157.4" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-01-31  ATTA21993A  Europe=390 [86.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1612" cy="504" r="10" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-01-31  ATTA21993A  North America=4 [15.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1612" cy="504" r="3" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-02-01 Europe=744</title>
	<line x1="1205.2" y1="1191.5" x2="1217.3" y2="1171.9" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-02-01 North America=49</title>
	<line x1="1217.3" y1="1171.9" x2="1224.4" y2="1160.3" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-02-01 Asia=5</title>
	<line x1="1224.4" y1="1160.3" x2="1227.6" y2="1155.0" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-02-01 South America=3</title>
	<line x1="1227.6" y1="1155.0" x2="1230.2" y2="1150.9" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-02-01  TT11083T  Europe=2 [0.3%]  orf1ab polyprotein, L3606F</title>
	<circle cx="1448" cy="797" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-02-01  ATTA21993A  Europe=345 [46.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1623" cy="511" r="10" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-02-01  ATTA21993A  North America=9 [18.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1623" cy="511" r="4" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-02-01  GTTA26158G  Europe=6 [0.8%]  ORF3a protein, V256D</title>
	<circle cx="1690" cy="401" r="3" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-02-01  TT26306T  Europe=2 [0.3%]  envelope protein, A22L</title>
	<circle cx="1693" cy="398" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-02-01  GTTT27204G  Europe=2 [0.3%]  ORF6 protein, F2H</title>
	<circle cx="1707" cy="374" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-02-01  TCTG28277T  Europe=2 [0.3%]  nucleocapsid phosphoprotein, S2Y</title>
	<circle cx="1725" cy="346" r="2" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-02-02 Europe=86</title>
	<line x1="1205.4" y1="1191.6" x2="1213.7" y2="1178.5" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-02-02 North America=37</title>
	<line x1="1213.7" y1="1178.5" x2="1220.5" y2="1167.8" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-02-02 Asia=6</title>
	<line x1="1220.5" y1="1167.8" x2="1224.2" y2="1162.1" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-02-02 South America=2</title>
	<line x1="1224.2" y1="1162.1" x2="1226.2" y2="1158.9" style="stroke:lime;" class="sb" />
</g>
<g>
	<title>2021-02-02  ATTA21993A  Europe=57 [66.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1635" cy="518" r="7" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-02-02  ATTA21993A  North America=2 [5.4%]  surface glycoprotein, Y145H</title>
	<circle cx="1635" cy="518" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-02-03 Europe=343</title>
	<line x1="1205.5" y1="1191.7" x2="1216.7" y2="1174.7" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-02-03 North America=33</title>
	<line x1="1216.7" y1="1174.7" x2="1223.5" y2="1164.5" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-02-03 Asia=5</title>
	<line x1="1223.5" y1="1164.5" x2="1226.9" y2="1159.3" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-02-03 Oceania=5</title>
	<line x1="1226.9" y1="1159.3" x2="1230.4" y2="1154.2" style="stroke:yellow;" class="sb" />
</g>
<g>
	<title>2021-02-03  ATTA21993A  Europe=305 [88.9%]  surface glycoprotein, Y145H</title>
	<circle cx="1647" cy="526" r="10" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-02-03  ATTA21993A  Europe=305 [88.9%] Oceania=5 [100.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1647" cy="526" r="3" style="fill:yellow;" class="cv" />
</g>
<g>
	<title>2021-02-03  ATTA21993A  Asia=3 [60.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1647" cy="526" r="2" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-02-04 Europe=120</title>
	<line x1="1205.7" y1="1191.8" x2="1215.1" y2="1178.0" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-02-04 North America=33</title>
	<line x1="1215.1" y1="1178.0" x2="1222.1" y2="1167.9" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-02-04 Asia=3</title>
	<line x1="1222.1" y1="1167.9" x2="1224.8" y2="1164.0" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-02-04  ATTA21993A  Europe=65 [54.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1658" cy="533" r="7" style="fill:cyan;" class="cv" />
</g>
<g>
	<title>2021-02-04  ATTA21993A  North America=4 [12.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1658" cy="533" r="3" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-02-05 North America=29</title>
	<line x1="1205.8" y1="1191.9" x2="1212.7" y2="1182.2" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-02-05 Asia=5</title>
	<line x1="1212.7" y1="1182.2" x2="1216.3" y2="1177.2" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-02-05  GTTT21989G  Asia=2 [40.0%]  surface glycoprotein, V143D</title>
	<circle cx="1670" cy="542" r="2" style="fill:white;" class="cv" />
</g>
<g>
	<title>2021-02-05  ATTA21993A  North America=2 [6.9%]  surface glycoprotein, Y145H</title>
	<circle cx="1670" cy="541" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-02-06 Europe=90</title>
	<line x1="1205.9" y1="1192.0" x2="1215.3" y2="1179.4" style="stroke:cyan;" class="sb" />
</g>
<g>
	<title>2021-02-06 North America=2</title>
	<line x1="1215.3" y1="1179.4" x2="1217.5" y2="1176.3" style="stroke:fuchsia;" class="sb" />
</g>
<g>
	<title>2021-02-06 Asia=5</title>
	<line x1="1217.5" y1="1176.3" x2="1221.2" y2="1171.3" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-02-06  ATTA21993A  North America=2 [100.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1681" cy="550" r="2" style="fill:fuchsia;" class="cv" />
</g>
<g>
	<title>2021-02-07 Asia=7</title>
	<line x1="1206.1" y1="1192.1" x2="1210.5" y2="1186.3" style="stroke:white;" class="sb" />
</g>
<g>
	<title>2021-02-07  GTTT21989G  Asia=2 [28.6%]  surface glycoprotein, V143D</title>
	<circle cx="1692" cy="558" r="2" style="fill:white;" class="cv" />
</g>
<rect x="1865" y="140" width="500" height="135" rx="15" style="fill:gainsboro;stroke-width:0;fill-opacity:0.15;" />
<text font-size="1.8em" x="1880" y="170" fill="white">Data from 6 continents</text>
<text font-size="1.8em" x="1880" y="200" fill="white">Total genomes10  Genomes/day2</text>
<text font-size="1.8em" x="1880" y="230" fill="white">38 distinct missense variants mapped</text>
<text font-size="1.8em" x="1880" y="260" fill="white">Updated 2021-02-12</text>
</svg>
